Skip to content
All news
MarketMove

CrowdStrike Rises 4.2% on Snowflake's Strong Results

CrowdStrike (CRWD) shares rose 4.2% after Snowflake's strong Q1 results provided clearer evidence that the 'SaaSpocalypse' fears were overstated for platforms at the center of AI workflows.

May 29, 2026
2 min read
Source: StockStory
Share:

Key Numbers

crwd price change
+4.2%
market value erased
$2 trillion

Shares of CrowdStrike (CRWD) rose 4.2% in afternoon trading after Snowflake's (SNOW) strong Q1 results provided clearer evidence that the so-called 'SaaSpocalypse' — a rolling selloff that erased approximately $2 trillion from software market values since late 2025 on fears that AI would make subscription software obsolete — had been overstated for platforms at the center of AI workflows.

Possible Reasons

  • Strong Snowflake Results: Snowflake reported quarterly results that beat expectations, boosting confidence that cloud data platforms remain in high demand.
  • SaaSpocalypse Fears Easing: Investors viewed Snowflake's performance as proof that subscription software models are still viable, especially those integrating AI.
  • Cybersecurity Sector: CrowdStrike, as a cybersecurity firm, benefits from rising demand for protection solutions in the AI era.

Context

The software sector has been in decline since late 2025, with a selloff erasing about $2 trillion in market value. However, Snowflake's results suggest investors may be reassessing companies that offer tangible value in AI.

Similar Moves in the Sector

No reports of similar moves for other stocks in the sector on the same day, but Snowflake's results are expected to positively impact other cloud software stocks.

Frequently Asked Questions

The stock rose 4.2% after Snowflake's strong results showed that fears of a software sector collapse (SaaSpocalypse) were overstated, boosting confidence in AI platforms.

Found this useful? Share it

Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.